Dr. Zhineng Jayson Yang, MD

Dr. Yang practices at Saint Luke's Hospital of Kansas City in Kansas City, Missouri, part of BJC Health.

Dr. Yang's NPI, 1285920694, was assigned on June 23, 2011. Dr. Yang holds Missouri license 2019043398.

Dr. Yang's primary practice is Saint Luke's Hospital of Kansas City, at 4401 Wornall Road, Kansas City, MO 64111 in Jackson County. The practice phone is (816) 932-2000.

Dr. Yang's primary practice is Saint Luke's Hospital of Kansas City in Kansas City, Missouri, part of BJC Health. Dr. Yang is also affiliated with Saint Luke's East Hospital. The medical group on file is Saint Luke's Medical Group. Dmand AI also links Dr. Yang to 2 more hospitals, 1 group practice or clinic, 1 home health agency and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yang practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Yang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Yang's licenses on file in 2 states: Missouri and Kansas.

CMS data shows 6,033 Medicare services from Dr. Yang across 36 procedure codes in 2024, for 628 Medicare patients. Medicare paid $137,548 for them.

CMS counts 628 Medicare patients who saw Dr. Yang in 2024. The largest group is 65 to 74, with 267 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yang's median patient age at 75, with 53% women.

In 2024, Dr. Yang wrote 2,526 Medicare Part D claims for 509 patients. 76% of them were for generic drugs. CMS names the drug for 2,065 of them, across 58 drugs with 11 or more claims each, at $5,221,667 in total drug cost. In 2023, CMS named 1,238 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Yang for performance year 2024, reported as part of a group. Dr. Yang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yang as offering telehealth.

Dmand AI links 9 papers to Dr. Yang, published from 2011 to 2013. 2011 was the busiest year, with 2. The most frequent topics are Autophagy. Dr. Yang has published most often in Blood Coagul Fibrinolysis. Dr. Yang's most frequent co-authors are Frank A. Sinicrope, MD, Cheng E. Chee, MD and Mounzer E. Agha, MD.

CMS Open Payments shows 150 general payments to Dr. Yang from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Millennium Pharmaceuticals, Inc. paid the most, $5,645.